143 related articles for article (PubMed ID: 8609750)
1. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy.
Habib FM; Springall DR; Davies GJ; Oakley CM; Yacoub MH; Polak JM
Lancet; 1996 Apr; 347(9009):1151-5. PubMed ID: 8609750
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.
Satoh M; Nakamura M; Tamura G; Makita S; Segawa I; Tashiro A; Satodate R; Hiramori K
J Am Coll Cardiol; 1997 Mar; 29(4):716-24. PubMed ID: 9091515
[TBL] [Abstract][Full Text] [Related]
3. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA).
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Grisorio B; Pellicelli A; Barbarini G
Circulation; 1999 Aug; 100(9):933-9. PubMed ID: 10468523
[TBL] [Abstract][Full Text] [Related]
4. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.
de Belder AJ; Radomski MW; Why HJ; Richardson PJ; Martin JF
Br Heart J; 1995 Oct; 74(4):426-30. PubMed ID: 7488459
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.
Torre-Amione G; Kapadia S; Lee J; Durand JB; Bies RD; Young JB; Mann DL
Circulation; 1996 Feb; 93(4):704-11. PubMed ID: 8640999
[TBL] [Abstract][Full Text] [Related]
6. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Grisorio B; Pellicelli AM; D'Amati G; Barbarini G;
AIDS; 2000 May; 14(7):827-38. PubMed ID: 10839591
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure.
Vejlstrup NG; Bouloumie A; Boesgaard S; Andersen CB; Nielsen-Kudsk JE; Mortensen SA; Kent JD; Harrison DG; Busse R; Aldershvile J
J Mol Cell Cardiol; 1998 Jun; 30(6):1215-23. PubMed ID: 9689595
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production and antibodies against heat shock protein 60 in cardiomyopathies of different origins.
Mándi Y; Hogye M; Talha EM; Skolák E; Csanády M
Pathobiology; 2000; 68(3):150-8. PubMed ID: 11174073
[TBL] [Abstract][Full Text] [Related]
9. Dilated cardiomyopathy in retrovirally infected mice: a novel model for silent viral DCM?
Beischel J; Larson DF; Yu Q; Yang B; Sepúlveda RT; Kelley T; Watson RR
Cardiovasc Toxicol; 2004; 4(4):317-25. PubMed ID: 15531775
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy.
Satoh M; Nakamura M; Saitoh H; Satoh H; Maesawa C; Segawa I; Tashiro A; Hiramori K
Circulation; 1999 Jun; 99(25):3260-5. PubMed ID: 10385500
[TBL] [Abstract][Full Text] [Related]
11. Expression of inducible nitric oxide synthase in human heart failure.
Haywood GA; Tsao PS; von der Leyen HE; Mann MJ; Keeling PJ; Trindade PT; Lewis NP; Byrne CD; Rickenbacher PR; Bishopric NH; Cooke JP; McKenna WJ; Fowler MB
Circulation; 1996 Mar; 93(6):1087-94. PubMed ID: 8653828
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes.
Song W; Lu X; Feng Q
Cardiovasc Res; 2000 Feb; 45(3):595-602. PubMed ID: 10728381
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of cytokine mRNA expression in hearts from patients with nonischemic dilated cardiomyopathy (DCM).
Ukimura A; Terasaki F; Fujioka S; Deguchi H; Kitaura Y; Isomura T; Suma H
J Card Surg; 2003; 18 Suppl 2():S101-8. PubMed ID: 12930277
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy.
Francis SE; Holden H; Holt CM; Duff GW
J Mol Cell Cardiol; 1998 Feb; 30(2):215-23. PubMed ID: 9514998
[TBL] [Abstract][Full Text] [Related]
15. Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.
Muranaka H; Marui A; Tsukashita M; Wang J; Nakano J; Ikeda T; Sakata R
J Thorac Cardiovasc Surg; 2010 Oct; 140(4):916-22. PubMed ID: 20381089
[TBL] [Abstract][Full Text] [Related]
16. Oxidative myocardial damage in human cocaine-related cardiomyopathy.
Frustaci A; Russo MA; Morgante E; Scopelliti F; Aquilano K; Ciriolo MR; Grande C; Verardo R; Chimenti C
Eur J Heart Fail; 2015 Mar; 17(3):283-90. PubMed ID: 25684178
[TBL] [Abstract][Full Text] [Related]
17. The time course of tumor necrosis factor-alpha, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats.
Heba G; Krzemiński T; Porc M; Grzyb J; Ratajska A; Dembińska-Kieć A
J Vasc Res; 2001; 38(3):288-300. PubMed ID: 11399901
[TBL] [Abstract][Full Text] [Related]
18. Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy.
Giam B; Chu PY; Kuruppu S; Smith AI; Horlock D; Murali A; Kiriazis H; Du XJ; Kaye DM; Rajapakse NW
Exp Physiol; 2018 Dec; 103(12):1593-1602. PubMed ID: 30311699
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tumor necrosis factor-alpha effect on the expression of iNOS in macrophage and cardiac myocytes.
Sanders DB; Larson DF; Hunter K; Gorman M; Yang B
Perfusion; 2001 Jan; 16(1):67-74. PubMed ID: 11192310
[TBL] [Abstract][Full Text] [Related]
20. Hyperubiquitination of proteins in dilated cardiomyopathy.
Weekes J; Morrison K; Mullen A; Wait R; Barton P; Dunn MJ
Proteomics; 2003 Feb; 3(2):208-16. PubMed ID: 12601813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
